Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
25.09. | Rubicon Organics to Present at Small Cap Discoveries in Vancouver and Planet MicroCap Showcase in Toronto | 3 | GlobeNewswire (USA) | ||
20.08. | Rubicon Organics wins price target raise at Haywood | 2 | Cantech Letter | ||
RUBICON ORGANICS Aktie jetzt für 0€ handeln | |||||
18.08. | Rubicon Organics übertrifft Prognosen mit Rekordumsatz im Q2 2025 | 3 | Investing.com Deutsch | ||
18.08. | Rubicon Organics Reports Q2 2025 Financial and Operating Results | 840 | GlobeNewswire (Europe) | Delivered Q2 2025 net revenue of $15.0 million, representing a 24% increase compared to the same quarter in prior year, and 2025 YTD net revenue of $27.4 million, representing a 30% increase compared... ► Artikel lesen | |
18.08. | Rubicon Organics GAAP EPS of C$0.01, revenue of C$14.98M | 1 | Seeking Alpha | ||
09.08. | Rubicon Organics Inc: Rubicon Organics to release Q2 2025 results Aug. 18 | 4 | Stockwatch | ||
08.08. | Rubicon Organics to Report Q2 2025 Results | 2 | GlobeNewswire (USA) | ||
01.08. | Rubicon Organics Announces the Results of the Annual General and Special Meeting, Appoints Chair & Grants DSUs | 157 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) ("Rubicon Organics" or the "Company"), a licensed producer focused on cultivating and... ► Artikel lesen | |
11.07. | Rubicon Organics Inc: Rubicon Organics to hold AGSM on July 31 | 5 | Stockwatch | ||
10.07. | Rubicon Organics to Hold Annual General and Special Meeting | 1 | GlobeNewswire (USA) | ||
03.07. | Rubicon Organics Launches 1964 Supply Co. All-in-One FSE Resin Vapes in Canada | 4 | GlobeNewswire (USA) | ||
05.06. | Rubicon Organics Inc: Rubicon closes cannabis cultivation plant acquisition | 1 | Stockwatch | ||
05.06. | Rubicon Organics Acquires Hope Facility to Accelerate Premium Cannabis Growth Strategy | 1 | GlobeNewswire (USA) | ||
02.06. | Zuanic and Associates initiates Rubicon Organics stock with Overweight rating | 2 | Investing.com | ||
02.06. | Zuanic and Associates stuft Rubicon Organics mit "Übergewichten" ein | 1 | Investing.com Deutsch | ||
30.05. | Rubicon Organics is undervalued, this analyst says | 3 | Cantech Letter | ||
28.05. | Rubicon Organics Reports Q1 2025 Financial and Operating Results | 170 | GlobeNewswire (Europe) | Achieved net revenue of $12.4 million, representing a 39.2% increase compared to the same quarter in prior yearGenerated Adjusted EBITDA1 of $0.7 million, an improvement of $1.1 million year-over-yearRemoved... ► Artikel lesen | |
22.05. | Rubicon Organics Clears Conditions for Hope Facility Acquisition, Advancing Growth Strategy | 1 | GlobeNewswire (USA) | ||
16.05. | Rubicon Organics to Report Q1 2025 Results | 2 | GlobeNewswire (USA) | ||
15.05. | Rubicon Organics Inc: Rubicon Organics appoints Ibbott as interim CFO | 5 | Stockwatch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
AURORA CANNABIS | 4,880 | +1,46 % | Aurora Cannabis Is Spiking. Barchart Options Data Tells Us ACB Stock Could Be Headed Here Next. | ||
CANOPY GROWTH | 1,178 | +1,73 % | As Trump Promotes CBD, Should You Buy, Sell, or Hold Canopy Growth Stock? | ||
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
TILRAY BRANDS | 1,375 | -0,15 % | Tilray Brands-Aktie +60%: Sorgt Trump für das große Comeback? | Am Montag ist die Aktie von Tilray Brands völlig unvermittelt um +60% nach oben geschossen. Dahinter steckt ausgerechnet US-Präsident Donald Trump. Kann er für ein Comeback der Papiere sorgen? Überraschende... ► Artikel lesen | |
INNOCAN PHARMA | 10,780 | -3,40 % | InnoCan Pharma: Vom CSE-Penny zum Nasdaq-Star! | ||
TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
CRONOS GROUP | 2,188 | -0,73 % | CRONOS - Cannabis-Aktie explodiert ans Rallyziel! | ||
SYNBIOTIC | 2,940 | -1,67 % | EQS-News: SYNBIOTIC SE: Gute Vorzeichen: Evaluierung der Cannabislegalisierung und Trump setzen positive Signale | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Studie/Sonstiges
Gute Vorzeichen: Evaluierung der Cannabislegalisierung und Trump setzen positive Signale
02.10.2025 / 13:26 CET/CEST
Für... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
ORGANIGRAM GLOBAL | 1,580 | -0,63 % | Organigram Global Inc: Organigram releases report on cannabis sector | ||
GREEN THUMB INDUSTRIES | 7,485 | +2,75 % | Cannabis-Aktien: AKTIONÄR-Tipp Green Thumb dreht auf | Zum Wochenstart verzeichnet der Cannabis-Sektor eine Renencance. Zweistellige Kursgewinne sind dabei keine Seltenheit. Grund für den neuen Boom bei den Kiffer-Aktien: US-Präsident Donald Trump hat ein... ► Artikel lesen | |
SNDL | 2,198 | -0,27 % | SNDL Inc.: SNDL Announces 2025 Annual and Special Meeting Results | EDMONTON, AB, July 31, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL" or the "Company") is pleased to announce the resolutions put to holders... ► Artikel lesen | |
CRESCO LABS | 1,256 | +7,08 % | Cresco Labs Inc. - 6-K, Report of foreign issuer | ||
MYDECINE INNOVATIONS GROUP | 0,003 | -73,91 % | Mydecine Innovations Group Inc (2): Mydecine Innovations has no material changes | ||
QUANTUM BIOPHARMA | 15,700 | -1,88 % | Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial | TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated... ► Artikel lesen |